TWO-COMPARTMENT ANTISEPTIC SOLUTION AND SPONGE APPLICATION PACKAGING
Patent Information
- Application Number
- TR202614340U
- Authority / Receiving Office
- TR · TR
- Patent Type
- Utility models
- Current Assignee / Owner
- Filing Date
- 2026-08-24
- Publication Date
- 2026-10-21
- Estimated Expiration
- 2036-08-24
AI Technical Summary
Current single-compartment packaging for antiseptic solutions allows prolonged contact between the solution and the sponge, leading to a decrease in antiseptic effectiveness due to iodine loss, adsorption, and sponge deterioration, which affects clinical performance and product quality.
A two-compartment packaging system is introduced, separating the antiseptic solution and sponge compartments to prevent premature contact, maintaining antiseptic efficacy by preserving free iodine and preventing sponge deterioration.
The packaging maintains the antiseptic solution's effectiveness by preventing iodine loss and sponge deterioration, ensuring reliable and homogeneous application during surgical site antisepsis.
Smart Images

Figure 00000007_0000 
Figure 00000008_0000 
Figure 00000008_0001
Abstract
Description
1 TARIFF TWO-COMPARTMENT ANTISEPTIC SOLUTION AND SPONGE APPLICATION PACKAGING Technical Area 5 The invention describes an antiseptic used for skin antisepsis prior to surgical procedures. solutions (e.g., povidone-iodine) and the products used in the application of these solutions It relates to packaging for sponges. The invention specifically addresses both the contact of the antiseptic solution with air and its premature application to the sponge. Two-compartment packaging that prevents contact, thus preserving antiseptic efficacy. It is related to. State of the Art 15 Skin antisepsis before surgical procedures is the most critical aspect of infection control. This is one of the stages, and povidone is one of the most commonly used antiseptics for this purpose. It is an iodine (PVP-I) solution. PVP-I is formed thanks to the iodine (I₂) that is free in the solution. It exhibits broad-spectrum antimicrobial activity. However, this solution is exposed to air for 20 minutes. Contact causes the antiseptic effectiveness to decrease over time. Therefore... Antiseptic solutions are usually packaged in sealed containers, often soaked into sponges. It is presented and its contact with air is cut off until the packaging is opened. However, the available In packaging types, prolonged contact of the solution with the sponge affects its antiseptic effectiveness. This leads to more serious chemical problems that reduce [the ability to absorb chemicals]. 25 The free iodine, which provides the microbial killing effect of povidone-iodine, is present in sponges. It is consumed by chemically reacting with the polymers in the material. In sponges polyurethane, cellulose and similar polymers used in production Plasticizers or catalysts react with iodine to oxidize it, and 30 It converts it into iodide (I⁻) ions, which have no germicidal power. This chemical This transformation causes the antiseptic solution to gradually become ineffective over its shelf life. In addition, free iodine physically or temporarily attaches to the polymer matrix of the sponge. It can be adsorbed by chemically binding. This adsorption mechanism, This is quite noticeable due to the porous structure and surface area of the sponge, and the 35 in the solution This leads to a decrease in free iodine concentration. Thus, the packaging 2 The actual antiseptic capacity of the solution is lower than expected when opened. is happening. Prolonged contact between the sponge and iodine only reduces antiseptic effectiveness. not only does it not remain, but it also causes physical deterioration in the sponge structure. 5 This is because iodine's strong oxidizing properties cause the sponge to lose its flexibility. crumbling, deterioration of the surface texture, and a change in color from dark brown to light brown. This causes it to turn yellow or white. This deterioration affects both the use of the product and its overall appearance. It lowers the quality and increases the risk of particle release during application, thus affecting clinical performance. This creates an undesirable situation from this point of view. 10 The vast majority of currently available commercial antiseptic applicators have a single-compartment packaging structure. It has this structure and is combined with the solution during the sponge production stage. This structure ensures that the solution... Since it does not contain any barrier preventing contact with the sponge, there is no loss of free iodine. It is inevitable. Some manufacturers use 15 methods to chemically stabilize the sponge. Although methods have been developed, these methods increase costs and biocompatibility. This poses risks and cannot completely eliminate iodine consumption. Therefore, current packaging technologies improve the chemical stability of the antiseptic solution. It is insufficient to provide protection, and its antiseptic effectiveness decreases throughout the product's shelf life. and reliability in clinical practice decreases. 20 For the reasons explained above, the current technique does not allow the antiseptic solution to be mixed with both air and air. the preservation of antiseptic efficacy due to prolonged contact with the sponge This is due to factors such as loss of free iodine, adsorption issues, and deterioration of the sponge structure. Problems during surgical preparation lead to undesirable outcomes. 25 In conclusion, the existence of the above problems and the inadequacy of the current solutions, This has made it necessary to make improvements in the technical field. Purpose of the Invention 30 The present invention eliminates the aforementioned disadvantages and contributes to the relevant technical field. with two-compartment antiseptic solution and sponge application packaging that brings new advantages. It is related. 35 3 The main purpose of the invention is to allow the antiseptic solution to come into contact with both air and the sponge. Two compartments that prevent early contact, thus preserving antiseptic efficacy. The goal is to present the packaging. The purpose of the invention is to chemically bond the antiseptic solution with polymers in the sponge material. A packaging solution was developed that prevents the loss of free iodine by reacting with the chemical. to place. Another aim of the invention is to prevent the sponge material from deteriorating over time due to the oxidizing effect of iodine. A packaging that prevents it from deteriorating, losing its flexibility and crumbling has been developed. to place. Another objective of the invention is to prevent oxidation of the antiseptic solution until the packaging is opened. sealed to provide protection against volatile substances and microbial contamination risks. The goal is to create a package that has a solution compartment. 15 Another purpose of the invention is to keep the brush sponge dry until it is used. This ensures optimum mechanical friction and distribution during application. The goal is to create packaging that features a foam compartment that delivers performance. Another purpose of the invention is to allow the foil on the packaging to be peeled off before use. the two compartments should be opened simultaneously and the solution should be applied to the sponge in a controlled manner. a package with an opening mechanism that makes transferring it possible to place. Another aim of the invention is to provide a fresh solution at each use in surgical site antisepsis. a packaging that enhances clinical efficacy by enabling the creation of a sponge combination to reveal. Another objective of the invention is to maintain the chemical stability of the antiseptic solution throughout its shelf life for 30 years. The goal is to create packaging that protects and standardizes product performance. To fulfill all the purposes mentioned above and those that can be derived from the detailed explanation. The invention refers to an antiseptic used for skin antisepsis before surgical procedures. 35 solutions (e.g., povidone-iodine) and the materials used in the application of these solutions This is a packaging specification for brush sponges, 4 - sponge compartment containing a sponge with a brush, - located next to the sponge compartment and containing a brush for soaking the sponge. an antiseptic solution compartment containing antiseptic solution, - Leakproof seal on the top surface of the sponge compartment and the antiseptic solution compartment. It is related to the fact that it contains at least one foil sealed in this way. 5 The structural and characteristic features and all the advantages of the invention are given in the figures below. And thanks to the detailed explanation written with references to these figures, it becomes clearer. This will be understood as such. Therefore, the evaluation should also include these forms and detailed explanations. This should be done taking this into consideration. 10 Figures that will help understand the invention. Figure 1: General view of the packaging that is the subject of the invention. Figure 2: Bottom view of the packaging that is the subject of the invention. 15 Figure 3: Side view of the packaging that is the subject of the invention. Explanation of Part References 10. Sponge compartment 20 20. Brush sponge 30. Antiseptic solution compartment Detailed Description of the Invention In this detailed description, the preferred alternatives to the packaging that is the subject of the invention are only to facilitate a better understanding of the subject and without creating any limiting effects. This is explained as follows. Figure 1 shows the general view of the packaging that is the subject of the invention. Accordingly, the packaging complies with EN 30. In its basic form; sponge compartment (10) containing brush sponge (20), sponge located next to the compartment (10) and inside which the brush sponge (20) is to be absorbed It contains an antiseptic solution compartment (30) containing antiseptic solution. The packaging subject to the invention consists of a sponge compartment (10) and an antiseptic solution compartment (30) 35 a packaging with two separate compartments, each created completely independently of the other It is the structure of the sponge compartment (10) and the antiseptic solution compartment (30) on top. The surface is sealed with at least one layer of foil. The sponge compartment (10) and the antiseptic solution compartment (30) form a single packaging body. It is designed with two completely independent compartments inside. 5 Sponge compartment (10) and antiseptic solution compartment (30), self-sealing perimeter. enclosed by walls, and until use, the sponge compartment (10) inside the brush sponge (20) and the antiseptic solution compartment (30) It is physically impossible for the antiseptic solution and the solution to come into contact with each other. This structure... thanks to the antiseptic solution in compartment (30) of the antiseptic solution, package 10 chemical reaction with the brush sponge (20) in the sponge compartment (10) until it opens It does not enter the body and does not lose its antiseptic effectiveness. For pre-surgical application, the sponge is removed from the foil on the packaging. Compartment (10) and compartment (30) of the antiseptic solution are opened at the same time. Foil 15 With the removal of the sponge compartment (10) and the antiseptic solution compartment (30) on top the surface becomes accessible for use and inside the antiseptic solution compartment (30) The stored antiseptic solution is placed inside the sponge compartment (10) by the user. It can be easily transferred. After this transfer, the brush sponge (20), antiseptic solution It is absorbed fresh and becomes ready for application. Thus, the antiseptic solution is 20 Until the packaging is opened, it has not come into contact with air and has not been cleaned with a brush sponge (20) early This prevents contact with the surface. This ensures the antiseptic effect of the antiseptic solution lasts longer. It is protected throughout and provides maximum effectiveness at the time of use. This method of use... Thanks to this, the loss of free iodine, which is one of the main problems of the current technique, is eliminated in the polymer. It completely eliminates the adsorption and deterioration of the brush sponge (20) structure. 25 The solution should only come into contact with the brush sponge (20) at the moment of use, antiseptic ensuring the effectiveness remains stable and provides a homogeneous, reliable result in surgical site antisepsis. This makes it possible to apply the brush. Keep the brush sponge (20) dry. Because of this, when it comes into contact with the antiseptic solution, optimum mechanical friction and It demonstrates a distribution performance, which effectively prepares the skin surface. 30 It provides. 35
Claims
6 REQUESTS 1. Antiseptic used for skin antisepsis before surgical procedures. solutions (e.g., povidone-iodine) and the application of these solutions This is a packaging for the packaging of the brush sponges (20) used, 5 feature; - sponge compartment (10) containing sponges with brushes (20), - located next to the sponge compartment (10) and containing a sponge with a brush (20) antiseptic solution containing antiseptic solution to be impregnated compartment (30), 10 - top of sponge compartment (10) and antiseptic solution compartment (30) It must contain at least one foil that is sealed airtight to its surface.
